海泰新光收盘下跌2.09%，滚动市盈率32.02倍，总市值45.98亿元

Group 1 - The core viewpoint of the articles highlights the financial performance and market position of Qindao Haitai Newlight Technology Co., Ltd., particularly in the medical device industry [1][2] - As of June 19, the company's stock closed at 38.36 yuan, with a decline of 2.09%, resulting in a rolling PE ratio of 32.02 times and a total market capitalization of 4.598 billion yuan [1] - The average PE ratio for the medical device industry is 48.08 times, with a median of 36.05 times, placing Qindao Haitai Newlight at the 70th position in the industry ranking [1][2] Group 2 - As of the first quarter of 2025, 26 institutions hold shares in Qindao Haitai Newlight, including 22 funds, 3 other institutions, and 1 social security fund, with a total holding of 57.068 million shares valued at 2.145 billion yuan [1] - The company's main business focuses on the research, development, manufacturing, sales, and service of medical endoscope instruments and optical products, including 4K fluorescence/white light laparoscopes and endoscope light source modules [1] - The latest financial results for the first quarter of 2025 show that the company achieved an operating income of 147 million yuan, a year-on-year increase of 24.86%, and a net profit of 46.6887 million yuan, up 21.45%, with a gross profit margin of 64.98% [1]